Company Filing History:
3 out of 88 
3 out of 116 
Years Active: 2019-2024
Title: Jürgen Klattig: Innovator in Antibody Development
Introduction
Jürgen Klattig is a notable inventor based in Peißenberg, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for therapeutic applications. With a total of 3 patents, Klattig's work focuses on innovative solutions for treating various medical conditions.
Latest Patents
One of Klattig's latest patents involves antibodies for IL-17C. This invention provides antibodies or antibody fragments that bind to human IL-17C. These antibodies have combined beneficial properties, making them useful for treating conditions such as atopic dermatitis and psoriasis. The potential impact of this invention is significant, as it addresses important health issues faced by many individuals.
Career Highlights
Throughout his career, Jürgen Klattig has worked with prominent companies in the biotechnology sector. Notably, he has been associated with Morphosys AG and Galapagos NV. His experience in these organizations has contributed to his expertise in antibody development and innovation.
Collaborations
Klattig has collaborated with several professionals in his field, including Jan Dominik Haas and Nick Ernest René Vandeghinste. These collaborations have likely enhanced his research and development efforts, leading to successful innovations.
Conclusion
Jürgen Klattig is a distinguished inventor whose work in antibody development has the potential to transform therapeutic approaches for various diseases. His contributions to the field are noteworthy, and his ongoing research continues to inspire advancements in biotechnology.